[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346533-105":59,"doc-detail-346533-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","therapeutic-landscape-of-hpv-associated-cancers-from-mechanisms-and-conventional-approaches-to-future-innovations","Therapeutic Landscape of HPV-Associated Cancers - From Mechanisms and Conventional Approaches to Future Innovations","","Cancer is a leading cause of mortality worldwide, and human papillomavirus acts as a widespread DNA virus with strong oncogenic capability, especially in high-risk genotypes such as HPV16 and HPV18. Persistent infection can progress to multiple malignancies, including cervical, oropharyngeal, anal, penile, vulvar, and vaginal cancers, with cervical cancer remaining most prevalent and disproportionately affecting low- and middle-income regions. This review summarizes HPV genome organization, oncogenic oncoproteins E6/E7, and viral DNA integration mechanisms, while covering diagnostic advances, therapeutic strategies, ongoing clinical trials, and future directions to reduce global disease burden.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/therapeutic-landscape-of-hpv-associated-cancers-from-mechanisms-and-conventional-approaches-to-future-innovations/346533/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/therapeutic-landscape-of-hpv-associated-cancers-from-mechanisms-and-conventional-approaches-to-future-innovations/346533.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Which HPV genotypes are most strongly linked to cancer development?","Question",{"text":113,"@type":114},"High-risk genotypes such as HPV16 and HPV18 are strongly associated with several human cancers. Low-risk types (e.g., HPV6 and HPV11) are more often linked to benign lesions rather than oncogenic transformation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do the viral oncoproteins E6 and E7 contribute to cancer?",{"text":118,"@type":114},"The review emphasizes that E6 and E7 work together to transform infected cells, supporting mechanisms that contribute to cancer development.",{"name":120,"@type":111,"acceptedAnswer":121},"What future approaches does the review highlight for reducing the global burden of HPV-related cancers?",{"text":122,"@type":114},"The review discusses advances in diagnostic technologies and emerging therapies, including immune-based treatments and therapeutic vaccines, along with ongoing clinical trials and future directions.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346533,1790141721,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review  \nTherapeutic Landscape of HPV-Associated Cancers: From Mechanisms and Conventional Approaches to Future Innovations  \nMuneera Anwer *, Krupa Bhaliya, Memoona Zahra, Urooj Yousaf Virk, Hafiza Aasia Malik and Ming Q. Wei  \nAcademic Editor: Beata Biesaga  \nReceived: 4 February 2026  \nAccepted: 11 February 2026  \nPublished: 15 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nSchool of Pharmacy and Medical Science, Griffith University, Gold Coast Campus, Gold Coast, QLD 4215, Australia  \n* [Correspondence: muneera.anwer@griffithuni.edu.au](Correspondence: muneera.anwer@griffithuni.edu.au)  \nSimple Summary  \nHuman papillomavirus (HPV) is a common viral infection that can lead to several types of cancer, including cervical, anal, vulvar, vaginal, and certain head and neck cancers. Although preventive vaccines have significantly reduced new infections, many HPV-related cancers still occur worldwide. This review explains how HPV causes cancer, outlines the different cancer types linked to the virus, and discusses current strategies for prevention, screening, and treatment. We also highlight recent advances in molecular diagnostics and emerging therapies, including immune-based treatments and therapeutic vaccines. By bringing together current knowledge on prevention and treatment, this article aims to clarify the evolving clinical landscape of HPV-associated cancers and identify areas for further research. A better understanding of these developments may support improved patient outcomes and guide future innovation in cancer therapy.  \nAbstract  \nCancer remains the second leading cause of mortality worldwide. Human papillomavirus is a widespread DNA virus with well-established oncogenic potential, particularly among high-risk genotypes such as HPV16 and HPV18 . Persistent infection with these genotypes can lead to the development of several malignancies, including cervical, oropharyngeal, anal, penile, vulvar, and vaginal cancers. Cervical cancer persists as the most prevalent malignancy associated with HPV infection, disproportionately affecting low-and middleincome countries. This review provides an overview of the HPV genome, viral genotypes, and associated malignancies, with particular emphasis on the viral oncoproteins E6 and E7 and the mechanisms of viral DNA integration into the host genome. In addition, recent advances in diagnostic technologies, therapeutic strategies, ongoing clinical trials, and future directions to reduce the global burden of HPV-related cancers are discussed.  \nKeywords: human papillomavirus; HPV-associated cancers; viral oncoproteins; E6; E7; immunotherapy; vaccines  \n1. Human Papillomavirus  \nHuman papillomavirus (HPV) belongs to the family Papillomaviridae and comprises small, non-enveloped double-stranded DNA viruses. Papillomaviruses possess a genome of approximately 8000 base pairs. HPV can infect squamous epithelium, or cells with the potential for squamous maturation, leading to the development of proliferative lesions.  \nThese viruses exhibit species specificity and strong tissue tropism, primarily targeting the skin surface or internal squamous mucosal tissues [1] . Until now, researchers have identified approximately 130 or more types of HPV, primarily through sequencing the genes encoding the capsid protein L1 [2] . The HPV genome is organised into three main regions: a noncoding upstream regulatory region (URR) of approximately 1 kilobase, an early region containing open reading frames (ORFs) E1, E2, E4, E5, E6, and E7, and a late region that encodes the L1 and L2 proteins, which form components of the viral capsid [3] . Figure 1 illustrates the genomic organisation of the HPV virus. Among these proteins, E1, E2, E4, and E5 are essential for viral DNA replication. The oncogenic proteins E6 and E7 work together to tra","cbCaisQ0U8Q7cbT7","https://ap.wps.com/l/cbCaisQ0U8Q7cbT7","pdf",3349401,29,"English","# Human Papillomavirus\n## HPV genome and structure\n## Viral regions and key proteins\n## High-risk and low-risk genotypes\n# Mechanisms of HPV-induced carcinogenesis\n## Roles of E6 and E7\n## Viral DNA integration into the host genome\n# Current clinical landscape and future innovations\n## Diagnostic technologies\n## Therapeutic strategies and clinical trials","[{\"question\":\"Which HPV genotypes are most strongly linked to cancer development?\",\"answer\":\"High-risk genotypes such as HPV16 and HPV18 are strongly associated with several human cancers. Low-risk types (e.g., HPV6 and HPV11) are more often linked to benign lesions rather than oncogenic transformation.\"},{\"question\":\"How do the viral oncoproteins E6 and E7 contribute to cancer?\",\"answer\":\"The review emphasizes that E6 and E7 work together to transform infected cells, supporting mechanisms that contribute to cancer development.\"},{\"question\":\"What future approaches does the review highlight for reducing the global burden of HPV-related cancers?\",\"answer\":\"The review discusses advances in diagnostic technologies and emerging therapies, including immune-based treatments and therapeutic vaccines, along with ongoing clinical trials and future directions.\"}]","Therapeutic Landscape of HPV-Associated Cancers - From Mechanisms and Conventional Approaches to Future Innovations | PDF",1790061862,73,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50208e5957336087f424acb2cd155f0a.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd148db6f943b916dfa7f14321997384.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f270753a3534e3f1e63ea54b39a7896f.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b70c1d2f9fb1a7feb6f504f41c1e6726.webp",980,1385]